Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this pilot study is to determine whether neoadjuvant
capecitabine/oxaliplatin/cetuximab and external beam radiation therapy followed by surgical
resection [and then followed by post operative adjuvant capecitabine, oxaliplatin and
cetuximab] is feasible and tolerable.